6.1.2006 Official Journal of the European Union L 3/3 COMMISSION REGULATION (EC) No 6/2006 of 5 January 2006 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards dihydrostreptomycin, tosylchloramide sodium and Piceae turiones recentes extractum (Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the estab- lishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (!), and in particular Articles 2 and 3 thereof, Having regard to the opinions of the European Medicines Agency formulated by the Committee for Medicinal Products for Veterinary Use, Whereas: (1) All pharmacologically active substances which are used within the Community in veterinary medicinal products intended for administration to food-producing animals should be evaluated in accordance with Regulation (EEC) No 2377/90. (2)  Dihydrostreptomycin has been included in Annex I to Regulation (EEC) No 2377/90 for bovine and ovine species, for muscle, fat, liver, kidney and milk, and for porcine species for muscle, liver, kidney and skin and fat in natural proportions. That entry should be extended from bovine and ovine species to all ruminants. () O] L 224, 18.8.1990, p. 1. Regulation as last amended by Commission Regulation (EC) No 1911/2005 (O] L 305, 24.11.2005, p. 30). (3)  Tosylchloramide has been included in Annex II to Regu- lation (EEC) No 2377/90 for fin fish for water borne only and for bovine for topical use only. That entry should be extended to Equidae for topical use only. (4 An application for establishing of maximum residue limits for Piceae turiones recentes extractum has been submitted. This substance should be included in Annex II to that Regulation for all food producing species for oral use only. (5)  Regulation (EEC) No 2377/90 should be amended accordingly. (6)  An adequate period should be allowed before the appli- cability of this Regulation in order to enable Member States to make any adjustment which may be necessary in the light of this Regulation to the marketing author- isations granted in accordance with  Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products (3). (7)  The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products, HAS ADOPTED THIS REGULATION: Article 1 Annexes [ and I to Regulation (EEC) No 2377/90 are amended in accordance with the Annex to this Regulation. () OJ L 311, 28.11.2001, p. 1. Directive as last amended by Directive 2004/28[EC (O] L 136, 30.4.2004, p. 58).